The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Open accessAbstract
Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation. In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance. For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance. Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity. These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment. While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage, resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype. Despite their higher capacity to repair tissue, the precise role of alternatively activated macrophages in obesity-induced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-gamma (PPARgamma), we show here that PPARgamma is required for maturation of alternatively activated macrophages. Disruption of PPARgamma in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, STAT1 and IRF5 have been shown to be involved in polarization and maintenance of an M1 phenotype while STAT6, IRF4, CREB-C/EBPβ, and PPARγ are involved in polarization and maintenance of an M2 phenotype [23–30].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [29]
In the citing paper
“Studies in PPARγ deficient mice exhibit impaired M2 macrophage function and susceptibility to diet-induced inflammation and insulin resistance [29,65–67].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [29]
In the citing paper
“In normal, non-obese subjects ATMs have a polarized M2 phenotype characterized by increased baseline STAT6 and PPARγ expression [29].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [29]
In the citing paper
“Importantly, the PPARγ nuclear receptor appears to be required for the maturation of alternatively activated macrophages (112, 113).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [113]
In the citing paper
“Accordingly, because of their proinflammatory properties, these macrophages are implicated in the pathogenesis of insulin resistance (103, 105, 112, 113).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Self-citationInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,061
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,006
Wentworth, J. M., Naselli, G., Brown, W. A., Doyle, L., Phipson, B., Smyth, G. K., Wabitsch, M., O’Brien, P. E., & Harrison, L. C. (2010) · Diabetes · doi:10.2337/db09-0287 · Cited by 636
The inflammation highway: metabolism accelerates inflammatory traffic in obesity
Johnson, A. R., Justin Milner, J., & Makowski, L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01151.x · Cited by 603
“Indeed, manipulation of the macrophage population can ameliorate or worsen pathology (75, 80, 84).”
BackgroundThe macrophage switch in obesity development
Castoldi, A., Naffah de Souza, C., Câmara, N. O. S., & Moraes-Vieira, P. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00637 · Cited by 575
Adipokine dysregulation and adipose tissue inflammation in human obesity
Unamuno, X., Gómez‐Ambrosi, J., Rodríguez, A., Becerril, S., Frühbeck, G., & Catalán, V. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12997 · Cited by 610
“By contrast, anti‐inflammatory Th2 cells and Treg cells, through production of IL‐4, IL‐10 and IL‐13, regulate macrophage function by promoting differentiation towards an M2 macrophage phenotype.(56,66,70) During adipose tissue expansion, the increasing ratios of Th1:Treg and Th1:Th2 cells are possibly responsible for…”
BackgroundLipid Metabolism in Regulation of Macrophage Functions
Yan, J., & Horng, T. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.09.006 · Cited by 569
Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit
Nadjsombati, M. S., McGinty, J. W., Lyons-Cohen, M. R., Jaffe, J. B., DiPeso, L., Schneider, C., Miller, C. N., Pollack, J. L., Nagana Gowda, G. A., Fontana, M. F., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.06.016 · Cited by 556
Obesity, Hypertension, and Cardiac Dysfunction
Mouton, A. J., Li, X., Hall, M. E., & Hall, J. E. (2020) · Circulation Research · doi:10.1161/circresaha.119.312321 · Cited by 561
Emerging role of adipose tissue hypoxia in obesity and insulin resistance
Ye, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.229 · Cited by 556
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
Mazzone, T., Chait, A., & Plutzky, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60768-0 · Cited by 552
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?
Parisi, L., Gini, E., Baci, D., Tremolati, M., Fanuli, M., Bassani, B., Farronato, G., Bruno, A., & Mortara, L. (2018) · Journal of Immunology Research · doi:10.1155/2018/8917804 · Cited by 508
“In contrast, M2 macrophage activation appears to protect against obesity-associated inflammation and insulin resistance [155, 156].”
BackgroundLu, Y., Yang, A., Quan, C., Pan, Y., Zhang, H., Li, Y., Gao, C., Lu, H. X., Wang, X., Cao, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-022-32283-3 · Cited by 564
Kadl, A., Meher, A. K., Sharma, P. R., Lee, M. Y., Doran, A. C., Johnstone, S. R., Elliott, M. R., Gruber, F., Han, J., Chen, W., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215715 · Cited by 573
Macrophage plasticity in experimental atherosclerosis
Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A.-T., Clement, M., Dussiot, M., Levillain, O., Graff-Dubois, S., Nicoletti, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008852 · Cited by 517
“polarization studies showed that the lack of ApoE favors the reparative M2 phenotype in response to IL-4. The more pronounced M2 potential of ApoE KO MO was not due to increased availability of the receptor to IL-4 but rather to an increased expression of peroxisome proliferator-activated receptor (PPAR)γ, a major tra…”
BackgroundSolinas, G., Vilcu, C., Neels, J. G., Bandyopadhyay, G. K., Luo, J.-L., Naugler, W., Grivennikov, S., Wynshaw-Boris, A., Scadeng, M., Olefsky, J. M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.011 · Cited by 513
“In addition, the effects of PPAR activation on insulin sensitivity are also in part attributed to anti-inflammatory action in myeloid cells (Hevener et al., 2007; Odegaard et al., 2007).”
BackgroundRecent progress in phospholipase A2 research: From cells to animals to humans
Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., & Yamamoto, K. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.12.001 · Cited by 517
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition
Hameed, I., Masoodi, S. R., Mir, S. A., Nabi, M., Ghazanfar, K., & Ganai, B. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.598 · Cited by 535
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
Wang, X., Ota, N., Manzanillo, P. S., Kates, L., Zavala‐Solorio, J., Eidenschenk, C., Zhang, J., Lesch, J., Lee, W. P., Ross, J., et al. (2014) · Nature · doi:10.1038/nature13564 · Cited by 512
Immune Regulation of Metabolic Homeostasis in Health and Disease
Brestoff, J. R., & Artis, D. (2015) · Cell · doi:10.1016/j.cell.2015.02.022 · Cited by 510
“Early studies linking AAMacs to metabolism demonstrated that macrophage-specific deletion of Peroxisome proliferator-associated receptor (PPAR)-g results in decreased AAMacs in WAT in association with increased weight gain, elevated fat accumulation, impaired glucose uptake and insulin resistance following HFD feeding…”
Metabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
“Similarly, macrophages that utilize FAO appear to increase efferocytosis via PPAR activation [327].”
BackgroundInfluentialRedox regulation of immunometabolism
Muri, J., & Köpf, M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00478-8 · Cited by 519
Xu, L., Nagata, N., Nagashimada, M., Zhuge, F., Ni, Y., Chen, G., Mayoux, E., Kaneko, S., & Ota, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.028 · Cited by 512
“Obesity or ectopic fat accumulation induces an innate immune response with the subsequent recruitment of immune cells, which ultimately leads to the development of insulin resistance and nonalcoholic steatohepatitis (NASH).”
BackgroundInfluentialEpigenetic regulation of the alternatively activated macrophage phenotype
Ishii, M., Wen, H., Corsa, C. A. S., Liu, T., Coelho, A. L., Allen, R., Carson, W. F., Cavassani, K. A., Li, X., Lukacs, N. W., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217620 · Cited by 505
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes
Soccio, R. E., Chen, E. R., & Lazar, M. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.005 · Cited by 518
“PPARg is expressed in macrophages and affects their phenotype, as PPARg (Odegaard et al., 2007) and TZDs (Bouhlel et al., 2007) lead to alternative M2 polarization, as opposed to classic proinflammatory M1 polarization.”
BackgroundPan, Y., Hui, X. H., Hoo, R. L. C., Ye, D., Chan, C. Y. C., Feng, T., Wang, Y., Lam, K. S. L., & Xu, A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123069 · Cited by 505
Inflammatory cytokines in general and central obesity and modulating effects of physical activity
Schmidt, F. M., Weschenfelder, J., Sander, C., Minkwitz, J., Thormann, J., Chittka, T., Mergl, R., Kirkby, K. C., Faßhauer, M., Stumvoll, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121971 · Cited by 483
“IL-4 and IL-13 are able to generate a M2-state and disrupting M2 activation leads to obesity and IR [63, 64].”
BackgroundControl of Macrophage Activation and Function by PPARs
Chawla, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.216523 · Cited by 531
Self-citationMyers, K. V., Amend, S. R., & Pienta, K. J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1022-2 · Cited by 490
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Baffy, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.008 · Cited by 487
“While PPARc promotes alternative activation of macrophages that contribute to valuable metabolic changes such as improved insulin sensitivity [93,94], recent research indicates that PPARd is specifically required for a similar program in Kupffer cells [95,96].”
BackgroundObesity, Inflammation, and Immune System in Osteoarthritis
Nedunchezhiyan, U., Varughese, I., Sun, A. R., Wu, X., Crawford, R., & Prasadam, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907750 · Cited by 507
“Role of PPAR y in macrophage activation (37, 38) (50)”
BackgroundThe role of adipose tissue immune cells in obesity and low-grade inflammation
Mraz, M., & Haluzik, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0283 · Cited by 543
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 469
Obesity and asthma: Possible mechanisms
Shore, S. A. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.03.004 · Cited by 459
Szántó, A., Bálint, B. L., Nagy, Z. S., Barta, E., Dezsö, B., Pap, A., Széles, L., Póliska, S., Oros, M., Evans, R. M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.009 · Cited by 462
“PPARg was also reported to be required for maturation of alternatively activated macrophages and disruption of the gene impaired alternative macrophagelinked functions in mice (Odegaard et al., 2007).”
BackgroundThe role of infiltrating immune cells in dysfunctional adipose tissue
Guzik, T. J., Skiba, D. S., Touyz, R. M., & Harrison, D. G. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx108 · Cited by 462
“type by regulating fatty acid storage and, in doing so, reduces obesity and improves insulin resistance (Figure 2).(119) While the metabolic state plays a role in macrophage recruitment and polarization, ATMs in turn have important effects on AT metabolism (Figure 2).”
BackgroundAdipose tissue macrophages: their role in adipose tissue remodeling
Suganami, T., & Ogawa, Y. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0210072 · Cited by 455
Macrophages in Lung Injury, Repair, and Fibrosis
Cheng, P., Li, S., & Chen, H. (2021) · Cells · doi:10.3390/cells10020436 · Cited by 457
Inflammation, microglia, and alzheimer's disease
Cameron, B., & Landreth, G. E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.006 · Cited by 452
“…coordinated by two members of the peroxisome proliferator-activated receptor family, PPARγ and PPARβ/δ (Kang et al., 2008; Odegaard and Chawla, 2008; Odegaard et al., 2007; Odegaard et al., 2008), which act to regulate the program of gene expression that characterizes this macrophage phenotype…”
BackgroundRole of innate and adaptive immunity in obesity-associated metabolic disease
McLaughlin, T., Ackerman, S. E., Shen, L., & Engleman, E. G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88876 · Cited by 462
“An M2 phenotypic shift can also be induced by PPARγ activation, which protects against M1 activation and IR (45), possibly by promoting lipid storage in adipocytes and preventing lipotoxicity and adipocyte death (46).”
BackgroundYang, H., Zhang, Q., Xu, M., Wang, L., Chen, X., Feng, Y., Li, Y., Zhang, X., Cui, W., & Jia, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01165-x · Cited by 449
Yang, H., Youm, Y., Vandanmagsar, B., Ravussin, A., Gimble, J. M., Greenway, F. L., Stephens, J. M., Mynatt, R. L., & Dixit, V. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000021 · Cited by 455
PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action
Hernández-Quiles, M., Broekema, M. F., & Kalkhoven, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.624112 · Cited by 459
“Next to macrophage and DC differentiation and macrophage polarization, PPARg can also directly regulate lipid metabolism in immune cells (37, 87, 92, 97, 98), reminiscent of its role in”
BackgroundImmunological Goings-on in Visceral Adipose Tissue
Mathis, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.008 · Cited by 449
“…are granulocytes, releasing a broad array of pro- and anti-inflammatory mediators, in particular IL-4 and IL-13, known to be crucial for the differentiation and survival of anti-inflammatory, M2-like macrophages, including those residing in adipose tissue (Odegaard et al., 2007; Kang et al., 2008).”
BackgroundEndoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes
Hummasti, S., & Hotamışlıgil, G. S. (2010) · Circulation Research · doi:10.1161/circresaha.110.225698 · Cited by 445
Macrophages and lipid metabolism
Remmerie, A., & Scott, C. L. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.020 · Cited by 451
Molofsky, A. B., Gool, F. V., Liang, H.-E., Dyken, S. J. V., Nussbaum, J. C., Lee, J., Bluestone, J. A., & Locksley, R. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.019 · Cited by 451
“…associated with type 2 immunity, including ILC2s, eosinophils, and AAMs, with Treg cells in visceral adipose tissue (VAT) of resting mice (Cipolletta et al., 2012; Feuerer et al., 2009; Molofsky et al., 2013; Odegaard et al., 2007; Qiu et al., 2014; Vasanthakumar et al., 2015; Wu et al., 2011).”
BackgroundControl of macrophage metabolism and activation by mTOR and Akt signaling
Covarrubias, A. J., Aksoylar, H., & Horng, T. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.08.001 · Cited by 433
Cellular Metabolism and Macrophage Functional Polarization
Zhu, L., Zhao, Q., Yang, T., Ding, W., & Zhao, Y. X. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.969421 · Cited by 438
“Furthermore, activation of PPARγ induced an anti-inflammatory M2 macrophage phenotype [77,78].”
BackgroundAdaptive immunity in obesity and insulin resistance
Sell, H., Habich, C., & Eckel, J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.114 · Cited by 486
SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity
Yoshizaki, T., Schenk, S., Imamura, T., Babendure, J. L., Sonoda, N., Bae, E. J., Oh, D. Y., Lu, M. M., Milne, J. C., Westphal, C. H., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00417.2009 · Cited by 432
Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation
Wang, F., Zhang, S., Vučković, I., Jeon, R., Lerman, A., Folmes, C. D. L., Dzeja, P. P., & Herrmann, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.012 · Cited by 414
“These steps are critical for facilitating lipid uptake and fatty acid synthesis and oxidation (Vats et al., 2006; Odegaard et al., 2007; Huang et al., 2014).”
BackgroundSignaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 490
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Musso, G., Cassader, M., & Gambino, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.3 · Cited by 424
Oxidative stress and inflammation interactions in human obesity
Bondia‐Pons, I., Ryan, L., & Martínez, J. A. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0154-2 · Cited by 420
Yang, Z., Kahn, B. B., Shi, H., & Xue, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123620 · Cited by 417
Macrophage Activation and Polarization as an Adaptive Component of Innate Immunity
Locati, M., Mantovani, A., & Sica, A. (2013) · Advances in immunology · doi:10.1016/b978-0-12-417028-5.00006-5 · Cited by 418
“and during helminth infection, Listeria infection, obesity, and cancer) (Auffray et al., 2007; Gustafsson et al., 2008; Odegaard et al., 2007; Rae et al., 2007; Raes et al., 2005).”
BackgroundInfluentialVersatile functions for IL-6 in metabolism and cancer
Mauer, J., Denson, J. L., & Brüning, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.008 · Cited by 415
Transcriptional Control of Macrophage Polarization
Tugal, D., Liao, X., & Jain, M. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301453 · Cited by 426
Macrophage polarization and plasticity in health and disease
Biswas, S. K., Chittezhath, M., Shalova, I. N., & Lim, J.-Y. (2012) · Immunologic Research · doi:10.1007/s12026-012-8291-9 · Cited by 406
“the role of this nuclear receptor in protecting against insulin resistance by promoting M2 activation [93].”
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 434
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 438
Zhuang, G., Meng, C., Guo, X., Cheruku, P. S., Shi, L., Xu, H., Li, H., Wang, G., Evans, A. R., Safe, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.087817 · Cited by 428
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Pello, Ó. M., Pizzol, M. D., Mirolo, M., Soucek, L., Zammataro, L. A., Amabile, A., Doni, A., Nebuloni, M., Swigart, L. B., Evan, G. I., et al. (2011) · Blood · doi:10.1182/blood-2011-02-339911 · Cited by 400
Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M. A., Vanhoutte, J., Copin, C., Sebti, Y., Derudas, B., Mayi, T., Bories, G., Tailleux, A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.233775 · Cited by 387
Usher, M. G., Duan, S. Z., Ivaschenko, C. Y., Frieler, R. A., Berger, S., Schütz, G., Lumeng, C. N.-K., & Mortensen, R. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41080 · Cited by 385
“This result may indicate that the MRKO macrophages are primed to polarize in the alternative activation direction, as was recently reported for stimulation of PPARγ (13).”
BackgroundRomeo, G. R., Lee, J., & Shoelson, S. E. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241869 · Cited by 396
“Finally, LysM-mediated deletion of peroxisome proliferator-activated receptor-γ led to HFD-induced increases in WAT proinflammatory cytokine expression and body weight, and to impaired β-oxidation and insulin sensitivity.(47) These”
Aron‐Wisnewsky, J., Tordjman, J., Poitou, C., Darakhshan, F., Hugol, D., Basdevant, A., Aissat, A., Guerre-Millo, M., & Clément, K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0925 · Cited by 379
Redox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377
“Mice with a functional deletion of PPARc in the myeloid lineage failed to generate a woundhealing macrophage phenotype (215).”
BackgroundImmunometabolism: From basic mechanisms to translation
Makowski, L., Chaib, M., & Rathmell, J. C. (2020) · Immunological Reviews · doi:10.1111/imr.12858 · Cited by 386
Vallée, A., & Lecarpentier, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00745 · Cited by 380
Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages
Bourlier, V., Zakaroff‐Girard, A., Miranville, A., Barros, S. D., Maumus, M., Sengenès, C., Galitzky, J., Lafontan, M., Karpe, F., Frayn, K. N., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.724096 · Cited by 390
Metabolic Reprograming in Macrophage Polarization
Galván-Peña, S., & O’Neill, L. A. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00420 · Cited by 944
“PPARγ on the other hand, is involved in the transcription of different factors required for β-oxidation of fatty acids (18, 19).”
BackgroundRegulation of Inflammation by Adenosine
Haskó, G., & Cronstein, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00085 · Cited by 367
Li, X. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms108 · Cited by 360
Macrophage polarization and meta-inflammation
Li, C., Xu, M. M., Wang, K., Adler, A. J., Vella, A. T., & Zhou, B. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.004 · Cited by 376
Shaul, M. E., Bennett, G., Strissel, K. J., Greenberg, A. S., & Obin, M. S. (2010) · Diabetes · doi:10.2337/db09-1402 · Cited by 383
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Villapol, S. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0554-5 · Cited by 386
Wang, H., Tian, T., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168470 · Cited by 364
“Additionally, downregulation of the peroxisome proliferator-activated receptor-γ (PPAR-γ) pathway in TAMs leads to increased secretion of itaconate, which functions as a regulator of M2 macrophages and promotes tumor progression [110,111].”
BackgroundSolinas, G., Schiarea, S., Liguori, M., Fabbri, M., Pesce, S., Zammataro, L. A., Pasqualini, F., Nebuloni, M., Chiabrando, C., Mantovani, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000413 · Cited by 373
PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
Mukundan, L., Odegaard, J. I., Morel, C. R., Heredia, J. E., Mwangi, J. W., Ricardo-Gonzalez, R. R., Goh, Y. P. S., Eagle, A. R., Dunn, S. E., Awakuni, J. U. H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2048 · Cited by 368
“Because we and others have previously shown that PPARs regulate the macrophage program of alternative activatio”
BackgroundSelf-citationShan, B., Wang, X., Wu, Y., Xu, C., Xia, Z., Dai, J., Shao, M., Zhao, F., He, S., Yang, L., et al. (2017) · Nature Immunology · doi:10.1038/ni.3709 · Cited by 367
McLaughlin, T., Liu, L.-F., Lamendola, C. A., Shen, L., Morton, J. M., Rivas, H., Winer, D. A., Tolentino, L. L., Choi, O., Zhang, H., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304636 · Cited by 382
Obesity, Inflammation, and Insulin Resistance – A Mini-Review
Zeyda, M., & Stulnig, T. M. (2009) · Gerontology · doi:10.1159/000212758 · Cited by 373
“JNK inhibitors may be interesting drugs for treatment of obesity-induced insulin resistance. Whether JNK inhibitors that are currently developed for blocking inflammation and tumor transformation will also be applicable for treatment of obesity-related diseases such as T2DM will have to be evaluated.The nuclear recept…”
BackgroundEtomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis
Divakaruni, A. S., Hsieh, W. Y., Minarrieta, L., Duong, T., Kim, K. K. O., Desousa, B. R., Andreyev, A. Y., Bowman, C. E., Caradonna, K. L., Dranka, B. P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.001 · Cited by 364
“…and Br€une, 2014), and PPARg (peroxisome proliferator-activated receptor g), a nuclear receptor controlling expression of lipid metabolism-related genes, is associated with and essential for alternative macrophage activation (Odegaard et al., 2007; Szanto et al., 2010; Vats et al., 2006).”
Regulating the adaptive immune response to respiratory virus infection
Braciale, T. J., Sun, J., & Kim, T. S. (2012) · Nature reviews. Immunology · doi:10.1038/nri3166 · Cited by 374
“Of note, activation of the nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ) — a transcription factor that controls the differentiation of monocyte precursors into alternatively activated macrophage”
BackgroundMandrekar-Colucci, S., Karlo, J. C., & Landreth, G. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5268-11.2012 · Cited by 355
“…have only recently been appreciated to play an crucial role in promoting the phenotypic change of macrophages from a “classically” M1 activated to alternatively activated M2 states (Odegaard et al., 2007, 2008; Zelcer et al., 2007; Bouhlel et al., 2008; Kalinin et al., 2009; Chawla, 2010).”
BackgroundHe, L., Jhong, J.-H., Chen, Q., Huang, K.-Y., Strittmatter, K., Kreuzer, J., DeRan, M., Wu, X., Lee, T.-Y., Slavov, N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109955 · Cited by 354
Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Monsalve, F. A., Pyarasani, R. D., Delgado‐López, F., & Moore‐Carrasco, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/549627 · Cited by 358
“In fact, inflammation a major determinant of health complications seen in overweight and obesity, which underscores the link between nutrition, metabolic organs, and the immune system, can be regulated by PPARs targets [19–21].”
Regulation of inflammation by interleukin-4: a review of "alternatives"
Luzina, I. G., Keegan, A. D., Heller, N. M., Rook, G. A. W., Shea-Donohue, T., & Atamas, S. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412214 · Cited by 351
Modulation of Macrophage Efferocytosis in Inflammation
Johnson, D. K., Frasch, S. C., Fernandez-Boyanapalli, R. F., Henson, P. M., & Bratton, D. L. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00057 · Cited by 362
“Collectively, these macrophages exhibit increased expression and/or activity of the nuclear receptors, PPARγ and PPARδ, essential to their acquisition of “alternative activation” (Bouhlel et al., 2007; Odegaard et al., 2007).”
BackgroundJNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347
“The latter is due to loss of the anti-inflammatory action of PPAR (32, 33).”
BackgroundMetabolic syndrome: from epidemiology to systems biology
Lusis, A. J., Attie, A., & Reue, K. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2468 · Cited by 345
N2 Neutrophils, Novel Players in Brain Inflammation After Stroke
Cuartero, M. I., Ballesteros, I., Moraga, A., Nombela, F., Vivancos, J., Hamilton, J. A., Corbí, A. L., Lizasoaín, I., & Moro, M. Á. (2013) · Stroke · doi:10.1161/strokeaha.113.002470 · Cited by 345
Galić, S., Fullerton, M. D., Schertzer, J. D., Sikkema, S. R., Marcinko, K., Walkley, C. R., Izon, D. J., Honeyman, J. E., Chen, Z., van Denderen, B. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58577 · Cited by 352
Liu, T. F., Vachharajani, V., Yoza, B. K., & McCall, C. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362343 · Cited by 339
Lumeng, C. N., Liu, J., Geletka, L., Delaney, C., Delproposto, J., Desai, A., Oatmen, K., Martinez-Santibanez, G., Julius, A., Garg, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102188 · Cited by 328
The Role of Macrophage Polarization in Infectious and Inflammatory Diseases
Labonte, A. C., Tosello‐Trampont, A., & Hahn, Y. S. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2374 · Cited by 347
“A recent study revealed that SARS-CoV-infected mice lacking hematopoeitic STAT1 expression have greater weight loss and lung pathology associated with upregulation of the M2 indicators YM1, FIZZ1, IL-4, and IL-13 (Page et al., 2012).”
BackgroundInfluentialInvestigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Ying, W., Cheruku, P. S., Bazer, F. W., Safe, S. H., & Zhou, B. (2013) · Journal of Visualized Experiments · doi:10.3791/50323 · Cited by 370
FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues
Garin-Shkolnik, T., Rudich, A., Hotamışlıgil, G. S., & Rubinstein, M. (2013) · Diabetes · doi:10.2337/db13-0436 · Cited by 344
“mice to the development of diet-induced obesity, insulin resistance, and glucose intolerance (12), whereas activation of PPARg within macrophages promotes lipid efflux, thereby stabilizing atherosclerotic lesions (13).”
BackgroundFuruhashi, M., Fucho, R., Görgün, C. Z., Tuncman, G., Cao, H., & Hotamisligil, G. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34750 · Cited by 332
“Similarly, specific and isolated deletion of target genes in the myeloid lineage has also produced support for the hypothesis that these cells impact systemic metabolic homeostasis (8, 9).”
BackgroundDepletion of fat-resident Treg cells prevents age-associated insulin resistance
Bapat, S. P., Suh, J. M., Fang, S., Liu, S., Zhang, K. Y., Cheng, A., Zhou, C., Liang, Y., Leblanc, M., Liddle, C., et al. (2015) · Nature · doi:10.1038/nature16151 · Cited by 334
Metadata
- Authors
- Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., & Chawla, A.
- Affiliations
- Stanford Medicine (US)
- Columbia University Irving Medical Center (US)
- University of Cape Town (ZA)
- Corresponding author
- Chawla, Ajay
- Venue
- Nature
- Published
- 2007-05-21
- Volume
- 447
- Issue
- 7148
- Pages
- 1116-1120
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2587297
- OpenAlex
- W2167485774
- Cited by
- 2,107
- References
- 32
- Citations by year
- 2026: 91 · 2025: 67 · 2024: 98 · 2023: 101 · 2022: 103 · 2021: 139 · 2020: 131 · 2019: 118 · 2018: 117 · 2017: 126 · 2016: 110 · 2015: 132 · 2014: 124 · 2013: 151 · 2012: 125
- FWCI
- 36.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL076746)
- National Institute of Allergy and Infectious Diseases (F31AI066402, T32AI007290)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK062386, R01DK076760, R01DK066525)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- PPARγ, macrophage polarization, alternative activation, insulin resistance, obesity, adipose tissue inflammation, CCR2, diet-induced obesity, impaired glucose tolerance, oxidative phosphorylation, skeletal muscle, liver, type 2 diabetes, myeloid cells, nutrient homeostasis
- MeSH terms
- Adipose Tissue, Animals, Cell Line, Dietary Fats, Glucose, Homeostasis, Insulin, Insulin Resistance, Macrophage Activation, Macrophages, Male, Mice, Inbred BALB C, Organ Size, Weight Gain, Leishmaniasis, Cutaneous, Leishmania major, Mice, Knockout, Genetic Predisposition to Disease, PPAR gamma, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
